Trial NCT03982992

View at ClinicalTrials.gov 
Org. Study IDs: 2017-002314-31

Last trial update was posted on 2024-03-12

MeSH Interventions

Blinatumomab

MeSH Conditions

Leukemia Leukemia, Lymphoid Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia in Remission Acute Lymphoblastic Leukemia, Adult B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation B-Cell Acute Lymphoblastic Leukemia

Stopping Reasons

Lack of potential study subjects due to a change of standard of care treatment outside of clinical trials.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID